CVS Health is weighing a potential breakup amid financial struggles, with the company under pressure from high medical costs and pharmacy reimbursement issues. Despite exploring splitting its retail pharmacy and insurance divisions, some analysts argue that separating the segments could be risky and may harm CVS’s integrated business model, which includes Aetna and Caremark.
The company has already initiated a $2 billion cost-cutting plan and laid off 3,000 employees, but it faces ongoing challenges, particularly within its insurance business. CEO Karen Lynch took over direct oversight of the insurance unit earlier this year to address rising costs from Medicare Advantage plans.
While some analysts see a breakup as unlikely, others argue that addressing CVS’s insurance issues is critical to improving its stock performance and overall financial health. Investors are expected to gain more clarity during CVS’s November earnings call.



